- Markets
- Healthcare
- TEJNAKSH
TEJNAKSH
New to Zerodha? Sign-up for free.
New to Zerodha? Sign-up for free.
-
Share Price
-
Financials
-
Revenue mix
-
Shareholdings
-
Peers
-
Forensics
- 5D
- 1M
- 6M
- YTD
- 1Y
- 5Y
- MAX
This data is currently unavailable for this company.
-
Summary
-
Profit & Loss
-
Balance sheet
-
Cashflow
This data is currently unavailable for this company.
(In Cr.) |
---|
(In Cr.) | ||||
---|---|---|---|---|
This data is currently unavailable for this company. |
(In %) |
---|
(In Cr.) |
---|
Financial Year (In Cr.) |
---|
-
Product wise
-
Location wise
Revenue Mix
This data is currently unavailable for this company.
Revenue Mix
This data is currently unavailable for this company.
Recent events
-
News
-
Corporate Actions
Tejnaksh Healthcare Approves Fund Raising Through Rights Issue Up To 50 Mln Rupees
Jan 23 (Reuters) - Tejnaksh Healthcare Ltd TEJN.BO:
BOARD APPROVES FUND RAISING THROUGH RIGHTS ISSUE UP TO 50 MILLION RUPEES
Source text: ID:nBSE2Q7fhj
Further company coverage: TEJN.BO
(([email protected];;))
Jan 23 (Reuters) - Tejnaksh Healthcare Ltd TEJN.BO:
BOARD APPROVES FUND RAISING THROUGH RIGHTS ISSUE UP TO 50 MILLION RUPEES
Source text: ID:nBSE2Q7fhj
Further company coverage: TEJN.BO
(([email protected];;))
Events:
Split
Bonus
Bonus
More Micro Cap Ideas
See similar 'Micro' cap companies with recent activity
Promoter Buying
Companies where the promoters are bullish
Capex
Companies investing on expansion
Superstar Investor
Companies where well known investors have invested
Popular questions
-
Business
-
Financials
-
Share Price
-
Shareholdings
What does Tejnaksh Healthcare do?
Tejnaksh Healthcare Ltd. operates the Institute of Urology hospital in Mumbai, Maharashtra, offering a range of urology and nephrology services including pediatric and adult urology, andrology, sexual dysfunction, dialysis, and renal transplant.
Who are the competitors of Tejnaksh Healthcare?
Tejnaksh Healthcare major competitors are Family Care Hospital, Global Longlife Hosp, Fortis MalarHospital, Aashka Hospitals, KMC Speciality Hosp, Dr Agarwals Eye Hsp, Shalby. Market Cap of Tejnaksh Healthcare is ₹49 Crs. While the median market cap of its peers are ₹243 Crs.
Is Tejnaksh Healthcare financially stable compared to its competitors?
Tejnaksh Healthcare seems to be less financially stable compared to its competitors. Altman Z score of Tejnaksh Healthcare is 5.17 and is ranked 4 out of its 8 competitors.
Does Tejnaksh Healthcare pay decent dividends?
The company seems to be paying a very low dividend. Investors need to see where the company is allocating its profits. Tejnaksh Healthcare latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%
How has Tejnaksh Healthcare allocated its funds?
Companies resources are allocated to majorly unproductive assets like Cash & Short Term Investments, Capital Work in Progress, Inventory, Short Term Loans & Advances
How strong is Tejnaksh Healthcare balance sheet?
Balance sheet of Tejnaksh Healthcare is strong. It shouldn't have solvency or liquidity issues.
Is the profitablity of Tejnaksh Healthcare improving?
Yes, profit is increasing. The profit of Tejnaksh Healthcare is ₹2.26 Crs for TTM, ₹1.78 Crs for Mar 2024 and ₹1.68 Crs for Mar 2023.
Is the debt of Tejnaksh Healthcare increasing or decreasing?
Yes, The debt of Tejnaksh Healthcare is increasing. Latest debt of Tejnaksh Healthcare is ₹1.14 Crs as of Sep-24. This is greater than Mar-24 when it was -₹2.54 Crs.
Is Tejnaksh Healthcare stock expensive?
Tejnaksh Healthcare is not expensive. Latest PE of Tejnaksh Healthcare is 21.42, while 3 year average PE is 41.7. Also latest EV/EBITDA of Tejnaksh Healthcare is 11.73 while 3yr average is 21.35.
Has the share price of Tejnaksh Healthcare grown faster than its competition?
Tejnaksh Healthcare has given lower returns compared to its competitors. Tejnaksh Healthcare has grown at ~-19.44% over the last 2yrs while peers have grown at a median rate of 17.06%
Is the promoter bullish about Tejnaksh Healthcare?
Promoters stake in the company seems stable, and we need to go through filings and allocation of resources to gauge promoter bullishness. Latest quarter promoter holding in Tejnaksh Healthcare is 73.83% and last quarter promoter holding is 73.83%.
Are mutual funds buying/selling Tejnaksh Healthcare?
There is Insufficient data to gauge this.